Genetic Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Component (Reagents & Consumables, Assays, Services), By Type (In Vitro v/s In Vivo), By Application (Pharmaceutical & Biotechnology, Cosmetics, Food, Others), By Region
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationGenetic Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Component (Reagents & Consumables, Assays, Services), By Type (In Vitro v/s In Vivo), By Application (Pharmaceutical & Biotechnology, Cosmetics, Food, Others), By Region
In 2015, 42 percent of all drugs, in development, had the potential to be personalized medicines, while 73 percent of oncology drugs had the potential to be personalized medicines in the United States.
Growing Demand for Personalized Medicine
Between 2006 and 2010, investment in personalized medicine in the United States grew by 73 percent, as per reports.
Increasing demand for genetic toxicology testing
With the increasing awareness about the potential health hazards associated with exposure to genotoxic agents, there is a growing demand for genetic toxicology testing. This is driving the growth of the global genetic toxicology testing market. Genetic toxicology testing can be used to identify substances that have the potential to cause genetic damage and mutations. This information can help regulators to set limits on exposure to these substances in order to minimize the risk of disease. Genetic toxicology testing is also used to assess the safety of pharmaceuticals. Before a new drug can be approved for use, it must undergo extensive safety testing, including genetic toxicology testing, to ensure that it does not cause mutations or other genetic damage that could lead to disease. Genetic toxicology testing can be used to evaluate the potential genotoxicity of environmental hazards such as air and water pollution, pesticides, and industrial chemicals. This information can be used to develop regulations to limit exposure to these hazards and protect public health. Genetic toxicology testing can also be used in the development of new treatments for diseases such as cancer. By identifying genotoxic substances that are specific to cancer cells, researchers can develop targeted therapies that minimize damage to healthy cells and maximize the effectiveness of the treatment.
Rising incidence of cancer
The increasing prevalence of cancer is also driving the growth of the genetic toxicology testing market. Genetic toxicology testing is used to assess the potential carcinogenicity of chemicals, drugs, and other substances, and is therefore a key tool in the fight against cancer. As the global population ages, the incidence of cancer is increasing. Cancer is more common in older adults, and as the proportion of older people in the population grows, so too does the incidence of cancer. Exposure to environmental factors such as air pollution, water pollution, and hazardous chemicals can increase the risk of cancer. As industrialization and urbanization continue to spread around the world, more people are being exposed to these environmental hazards. Lifestyle factors such as smoking, alcohol consumption, poor diet, lack of exercise, and obesity have been linked to an increased risk of cancer. As more people adopt unhealthy lifestyles, the incidence of cancer is increasing. Certain genetic mutations can increase the risk of developing cancer. While these mutations are relatively rare, they can be passed down from generation to generation and can increase the overall incidence of cancer. Improved diagnostic tools and screening programs have led to earlier detection of cancer, which can make it appear as though the incidence of cancer is increasing even if the actual number of cases remains the same. In 2020, there were an estimated 19.3 million new cancer cases and 10 million cancer deaths worldwide.
Increasing R&D activities
Federal government spending for health care grew 36.0% in 2020, significantly faster than the 5.9% growth in 2019.
Recent Development
- In 2021, Trevigen, a division of Bio-Techne Corporation, launched a new product called CometChip, which is a high-throughput comet assay that allows researchers to evaluate DNA damage in hundreds of samples simultaneously. The assay is designed to help researchers identify potential genotoxic agents and evaluate the effectiveness of DNA damage repair mechanisms.
- In 2020, Indivumed GmbH launched a new product called BlueScreen HC, which is a high-throughput genotoxicity screening assay that uses genetically engineered bacterial cells to detect DNA damage. The assay is designed to help researchers evaluate the safety of drugs, chemicals, and other compounds.
- In 2019, Gentronix Limited launched a new product called ToxiQuant®-Fluo, which is a high-throughput assay that measures DNA damage and repair in human cells. The assay is designed to help researchers evaluate the genotoxicity of compounds and potential cancer-causing agents.
Market Segmentation
Global genetic toxicology testing market can be segmented by component, by type, by application and by region. Based on component, the market can be segmented into Reagents & Consumables, Assays, Services. Based on type, the market can be divided into In Vitro and In Vivo. Based on application, the market can be grouped into Pharmaceutical & Biotechnology, Cosmetics, Food, Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global genetic toxicology testing market, on account of growing demand for personalized medicine and increasing investment in the healthcare industry in the country.
Market Players
Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Charles River Laboratories International, Inc., Merck KGaA, Toxikon Corporation, Gentronix Limited are some of the leading players operating in the Global Genetic Toxicology Testing Market.
Recent Developments
- Inotiv, Inc. in July 2022 announced that it would be continuing to expand its capacity to conduct genetic toxicology studies for in vitro cytogenetics and bacterial assays. This will help in supporting the development of novel therapeutics.
- In November 2021, United Kingdom based contract research organization, Gentronix announced that they have raised around USD 743,000(Euro 700) for the expansion of its lab facilities by enhancing its capacity for ocular, genetic, and skin toxicology testing.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | By Component By Type By Application By Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey |
| Key companies profiled | Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Charles River Laboratories International, Inc., Merck KGaA, Toxikon Corporation, Gentronix Limited |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy